Lynde C - Search Results

1

Chan B, Hales B, Shear N, Ho V, Lynde C, Poulin Y, Mittmann N. Chan B, et al. Among authors: lynde c. J Cutan Med Surg. 2009 Jul-Aug;13(4):192-7. doi: 10.2310/7750.2009.08068. J Cutan Med Surg. 2009. PMID: 19706226

2

Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004.

Guenther L, Langley RG, Shear NH, Bissonnette R, Ho V, Lynde C, Murray E, Papp K, Poulin Y, Zip C. Guenther L, et al. Among authors: lynde c. J Cutan Med Surg. 2004 Sep-Oct;8(5):321-37. doi: 10.1007/s10227-005-0035-1. J Cutan Med Surg. 2004. PMID: 15868311

3

Canadian guidelines for the management of plaque psoriasis: overview.

Papp K, Gulliver W, Lynde C, Poulin Y, Ashkenas J; Canadian Psoriasis Guidelines Committee. Papp K, et al. Among authors: lynde c. J Cutan Med Surg. 2011 Jul-Aug;15(4):210-9. doi: 10.2310/7750.2011.10066. J Cutan Med Surg. 2011. PMID: 21781627

4

Comparison of Management Guidelines for Moderate-to-Severe Plaque Psoriasis: A Review of Phototherapy, Systemic Therapies, and Biologic Agents.

Ighani A, Partridge ACR, Shear NH, Lynde C, Gulliver WP, Sibbald C, Fleming P. Ighani A, et al. Among authors: lynde c. J Cutan Med Surg. 2019 Mar/Apr;23(2):204-221. doi: 10.1177/1203475418814234. Epub 2018 Nov 21. J Cutan Med Surg. 2019. PMID: 30463416 Review.

5

The use of alefacept in the treatment of psoriasis.

Langley R, Gupta AK, Poulin Y, Guenther L, Barber K, Gulliver W, Lynde C. Langley R, et al. Among authors: lynde c. J Cutan Med Surg. 2004 Aug;8 Suppl:14-8. doi: 10.1007/s10227-004-2004-5. J Cutan Med Surg. 2004. PMID: 15655585 Review. No abstract available.

6

Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis.

Papp KA, Ho V, Langley R, Lynde C, Poulin Y, Shear N, Toole J, Zip C. Papp KA, et al. Among authors: lynde c. J Cutan Med Surg. 2006;9 Suppl 1:26-32. doi: 10.1007/s10227-006-0104-0. J Cutan Med Surg. 2006. PMID: 16633859 Review.

7

Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches.

Langley RG, Ho V, Lynde C, Papp KA, Poulin Y, Shear N, Toole J, Zip C. Langley RG, et al. Among authors: lynde c. J Cutan Med Surg. 2006;9 Suppl 1:18-25. doi: 10.1007/s10227-006-0103-1. J Cutan Med Surg. 2006. PMID: 16633860 Review.

8

Divergence of demographic factors associated with clinical severity compared with quality of life impact in acne.

Tan JK, Li Y, Fung K, Gupta AK, Thomas DR, Sapra S, Lynde C, Poulin Y, Gulliver W, Sebaldt RJ. Tan JK, et al. Among authors: lynde c. J Cutan Med Surg. 2008 Sep-Oct;12(5):235-42. doi: 10.2310/7750.2008.07053. J Cutan Med Surg. 2008. PMID: 18845093

9

Canadian hand dermatitis management guidelines.

Lynde C, Guenther L, Diepgen TL, Sasseville D, Poulin Y, Gulliver W, Agner T, Barber K, Bissonnette R, Ho V, Shear NH, Toole J. Lynde C, et al. J Cutan Med Surg. 2010 Nov-Dec;14(6):267-84. doi: 10.2310/7750.2010.09094. J Cutan Med Surg. 2010. PMID: 21084020 Review.

10

Etanercept improves quality of life outcomes and treatment satisfaction in patients with moderate to severe plaque psoriasis in clinical practice.

Vender R, Lynde C, Gilbert M, Ho V, Sapra S, Poulin-Costello M. Vender R, et al. Among authors: lynde c. J Cutan Med Surg. 2012 Nov-Dec;16(6):407-16. doi: 10.1177/120347541201600609. J Cutan Med Surg. 2012. PMID: 23149196 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

300 results

Search Page